PAP
Persistent Asset Partners Portfolio holdings
AUM
$114M
This Quarter Return
+2.01%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$113M
AUM Growth
+$113M
(-2.9%)
Cap. Flow
+$3.12M
Cap. Flow
% of AUM
2.76%
Top 10 Holdings %
Top 10 Hldgs %
41.39%
Holding
181
New
48
Increased
25
Reduced
30
Closed
34
Top Buys
| 1 |
Centene
CNC
|
$7.55M |
| 2 |
iShares Bitcoin Trust
IBIT
|
$7.05M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$4.43M |
| 4 |
Eli Lilly
LLY
|
$2.49M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$2.49M |
Top Sells
| 1 |
Humana
HUM
|
$9.26M |
| 2 |
DaVita
DVA
|
$4.96M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$3.51M |
| 4 |
Cardinal Health
CAH
|
$2.63M |
| 5 |
DFS
Discover Financial Services
DFS
|
$1.87M |
Sector Composition
| 1 | Healthcare | 63.66% |
| 2 | Financials | 21.94% |
| 3 | Materials | 3.92% |
| 4 | Energy | 1.87% |
| 5 | Industrials | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
VistaGen Therapeutics
VTGN
$109M
| $304K | 0.26% |
121,651
| – | – |
|
77
Ascendis Pharma
ASND
$12.2B
| $297K | 0.25% |
1,906
-7,034
| -79% | -$1.1M |
|
78
Mr. Cooper
COOP
$11.7B
| $286K | 0.24% |
2,388
-3,205
| -57% | -$383K |
|
79
Warrior Met Coal
HCC
$3.04B
| $285K | 0.24% |
+5,978
| New | +$285K |
|
80
Oracle
ORCL
$628B
| $280K | 0.23% |
+2,000
| New | +$280K |
|
81
Relay Therapeutics
RLAY
$633M
| $263K | 0.22% |
100,484
-45,344
| -31% | -$119K |
|
82
Trevi Therapeutics
TRVI
$873M
| $260K | 0.22% |
+41,404
| New | +$260K |
|
|
MREO
83
Mereo BioPharma
MREO
$278M
| $255K | 0.21% |
+113,247
| New | +$255K |
|
|
TGB
84
Taseko Mines
TGB
$1.04B
| $237K | 0.2% |
+105,769
| New | +$237K |
|
85
Graphic Packaging
GPK
$6.51B
| $233K | 0.2% |
8,966
-17,181
| -66% | -$446K |
|
86
Intel
INTC
$105B
| $227K | 0.19% |
+10,000
| New | +$227K |
|
87
Esquire Financial Holdings
ESQ
$820M
| $227K | 0.19% |
3,008
+211
| +8% | +$15.9K |
|
88
Pacira BioSciences
PCRX
$1.21B
| $223K | 0.19% |
+8,963
| New | +$223K |
|
89
FirstCash
FCFS
$6.59B
| $216K | 0.18% |
+1,794
| New | +$216K |
|
|
NBIS
90
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.5B
| $211K | 0.18% |
+10,000
| New | +$211K |
|
91
UroGen Pharma
URGN
$886M
| $194K | 0.16% |
+17,571
| New | +$194K |
|
92
Cytokinetics
CYTK
$5.86B
| $184K | 0.15% |
+4,576
| New | +$184K |
|
|
CLYM
93
Climb Bio, Inc. Common Stock
CLYM
$149M
| $178K | 0.15% |
145,760
| – | – |
|
94
Replimune Group
REPL
$454M
| $167K | 0.14% |
17,143
-11,960
| -41% | -$117K |
|
95
Clover Health Investments
CLOV
$1.34B
| $163K | 0.14% |
+45,276
| New | +$163K |
|
96
Reviva Pharmaceuticals
RVPH
$30.6M
| $153K | 0.13% |
160,310
-860
| -0.5% | -$820 |
|
97
loanDepot
LDI
$415M
| $145K | 0.12% |
+122,159
| New | +$145K |
|
|
SLSR
98
Solaris Resources
SLSR
$880M
| $141K | 0.12% |
41,812
| – | – |
|
99
Alector
ALEC
$256M
| $129K | 0.11% |
+104,927
| New | +$129K |
|
100
uniQure
QURE
$927M
| $88.9K | 0.07% |
+8,386
| New | +$88.9K |
|